Market revenue in 2024 | USD 127.3 million |
Market revenue in 2030 | USD 134.8 million |
Growth rate | 1% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.42% in 2024. Horizon Databook has segmented the Canada hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The hospital acquired infection (HAI) diagnostics market in Canada is driven by enhanced surveillance and reporting systems, increased public awareness and education, and advancements in infection prevention technologies.
Enhanced surveillance and reporting systems, such as the Canadian Nosocomial Infection Surveillance Program (CNISP), have been pivotal in monitoring HAI trends across the country. The competitive landscape of the Hospital Acquired Infection (HAI) diagnostics market in Canada is characterized by a combination of established companies and emerging players focused on offering innovative solutions to combat HAIs.
Major companies such as 3M, STERIS, Ecolab, and Getinge are at the forefront, leveraging advanced technologies and extensive research and development to enhance their product offerings. The companies operating in the market are actively involved in developing sterilization systems, disinfection products, and infection prevention solutions tailored to the unique needs of Canadian healthcare facilities.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account